Cite
HARVARD Citation
Mendell, J. et al. (n.d.). An open‐label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics. Journal of clinical pharmacology. pp. 1395-1405. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mendell, J. et al. (n.d.). An open‐label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics. Journal of clinical pharmacology. pp. 1395-1405. [Online].